VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
2.861
+0.041 (1.45%)
Nov 21, 2024, 2:32 PM EST - Market open
VYNE Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -34 | -28.45 | -23.21 | -73.33 | -255.57 | -95.18 | Upgrade
|
| Depreciation & Amortization | - | - | 0.07 | 0.11 | 0.34 | 0.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.28 | 0.09 | 2.1 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 54.35 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.15 | -0.26 | - | - | -0.14 | -0.36 | Upgrade
|
| Stock-Based Compensation | 3.31 | 3.31 | 4.3 | 8.08 | 18.1 | 4.9 | Upgrade
|
| Other Operating Activities | 0 | 0 | - | 3.9 | 84.07 | 0.2 | Upgrade
|
| Change in Accounts Receivable | -2.2 | 0.41 | 11.21 | 7.71 | -17.14 | 0.37 | Upgrade
|
| Change in Inventory | - | - | 0.1 | 0.11 | -6.05 | -1.36 | Upgrade
|
| Change in Accounts Payable | 4.81 | -0.56 | -8.68 | -2.68 | -12.98 | 18.05 | Upgrade
|
| Change in Other Net Operating Assets | 0.12 | 0.21 | -0.35 | -0.37 | -4.17 | -0.39 | Upgrade
|
| Operating Cash Flow | -30.11 | -25.34 | -29.2 | -56.37 | -137.08 | -73.39 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0.11 | -1.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.04 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 38.64 | - | Upgrade
|
| Investment in Securities | -51.73 | -62.35 | - | 1.03 | 50.58 | 42.89 | Upgrade
|
| Other Investing Activities | - | 5 | 15.67 | - | - | - | Upgrade
|
| Investing Cash Flow | -51.73 | -57.35 | 15.67 | 1.03 | 89.11 | 41.87 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 33.9 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -36.43 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -36.43 | - | 33.9 | Upgrade
|
| Issuance of Common Stock | 82.67 | 82.82 | 1.47 | 76.5 | 61.95 | 14.08 | Upgrade
|
| Repurchase of Common Stock | -0.01 | -0.07 | -0.03 | -0.29 | -0.14 | -0.03 | Upgrade
|
| Financing Cash Flow | 82.65 | 82.39 | 1.65 | 39.78 | 61.81 | 47.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | 0 | 0.04 | Upgrade
|
| Net Cash Flow | 0.82 | -0.3 | -11.88 | -15.56 | 13.83 | 16.47 | Upgrade
|
| Free Cash Flow | -30.11 | -25.34 | -29.2 | -56.37 | -137.2 | -74.45 | Upgrade
|
| Free Cash Flow Margin | -6107.51% | -5976.65% | -6121.59% | -6054.46% | -653.53% | -16806.32% | Upgrade
|
| Free Cash Flow Per Share | -0.76 | -2.47 | -9.17 | -19.72 | -76.18 | -157.94 | Upgrade
|
| Cash Interest Paid | - | - | - | 2.39 | 3.94 | 0.8 | Upgrade
|
| Levered Free Cash Flow | -15.45 | -12.25 | -11.86 | -15.97 | -86.93 | -40.27 | Upgrade
|
| Unlevered Free Cash Flow | -15.45 | -12.25 | -11.86 | -12.47 | -84.18 | -39.69 | Upgrade
|
| Change in Net Working Capital | -4.8 | -2.74 | -4.85 | -4.79 | 31.59 | -16.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.